RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Anne Coleman to Immunotherapy

Back to Details
This is a "connection" page, showing publications Anne Coleman has written about Immunotherapy.
Anne Coleman
Connection Strength
0.174
Immunotherapy
  1. Sun MM, Kelly SP, Mylavarapu Bs AL, Holland GN, Coleman AL, Yu F, Hsu Ms S, Lum F, Gordon LK. Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 2021 06; 128(6):910-919.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support